Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]

We.B.3 156, We.B.33 I12, We.C.3463, We.D.246, We.D.3608, We.D.36II, We.D.362 I, We.D.3626, We.D.363 1, WeD.3675, We.D.3682, We.D.3686, We.D.3688, We.D.3690, We.D.3694, We.D.3696, We.D.370, We.D.3700, We.D.370 I, We.D.3 725, We.D.3750, We.D.3772, We.[3.3784, We.D.3848, We.D.3858, We.D.3885, We.D.3897, We.D.39 I0, We.D.39 I12, We.D.39 16, We.D.47 1, We.D.492, We.D.6 10, We. D.61 I pets Th.C.456 I phagocytes We.A.3069 pharmaceutical industry Mo.B. 1174, Pub.C. 1 274, Th.C.4382, 7 h.C.4794,Th.D.375,Th.D.5 I1I8, We.B.3 I58 pharmacokinetics No.A. 1054, No.A. 1075, No.A. 1077, Mo.A. 1079, Mo.A. 1086, MoA. 1087, Mo.A.I I116, No.B.l 132, No.0. 1140, Mo.B. I1196, Mo.B. 1198, Mo.B. 1 199, Mo.B. 1200, Mo.B. 1324, No.8. 1325, Mo.B. I1326, Mo.B.1327, Mo.B. 1328, Mo.B. I1329, Mo.B. I 74, Th.A. 155, 7u.B.2 I I7,Tu.B.2283,Tu.B.2284, Tu.B.2322,To.B.2324, Tu.B.2327,Tu.C.445, We.B.3 I129, We.B.3 131,We.B.3 132, We.B.550 phenotype Mo.A.l III, PubA10lS, Pub.B.1081, Th.B.4272,Th.B.4328,Tu.A.203 I, 1ij.A.2060,Tu.B. I 93,Tu.B.2243,Tu.B.2244, Tu.B.2245, We.A.30 I15, We.A.3095, We.B.3 I130 phenotype, biological parameters Mo.A. I 005, Th.A.40 I19, Tu.A.2 0 II, Tu.A.2047, Tu.A.2072, Tu.A.2074, 4u.A.2088, We.B.3327 phenytoin Th.B. I186 phosphatidyl choline Mo.A. 057 photodynamic inactivation Mo.B.1251,We.B.3243 photosensitizer We.B.3243 phylogenetic Ma.C. 532, Na..667, Pub.A. 101 I, To.A.2059, Tu.A.2069, Tu.A.207 I, Tu.A.208 I, Tu.A.2084, Tu.A.2087, Tu.A.372,Tu.B.2242 physicians, SEE health care personnel No.8. I1I36, No.C.344,Th.B.4 145, -1'ih.C.4553,TLhhC.4554,Th.C.4555, ON\ Th.C.4676,Th.D.5020,Tu.D.2777 placebo > o.0. 1 40,Th.D.5l8l,Tu.B.l84 D placenta U Mo.A. I100, Pub.B. I 065,Tu.A. 145, roTu.A.2009, Tu.B.2325, Tu.B.4 I13, Tu.C.2575, Tu.C.2587,Tu.C.34 I, We.A.3098, L) We.A.3099, We.A.3 03, We.B. 19 I, n We.B. I194, We.C.3575 Th.A.4059,Th.A.4066, Th.D.5027, 4 4 Th.D.5l184,Tu.B.lI l0,Tu.B.lI I I,Tu.B.l112, Tu. B.I1I3, Tu. B.I1I4, Tu. B.I115, Tu. B.I116, Tu.B. I18 I,Tu.B.2 I46,Tu.B.2 I56,Tu.B.2 I61, Tu.B.2287,Tu.B.2288,Tu.B.2289, Tu. B.2290, Tu.B8.2292,TZu. B.229 3, Tu.B.2294,Tu.B.2295,Tu.B.2296, Tu.B.2297,Tu.B.2298,Tu.B,2299, Tu.B.2300,Tu.B.230 I,Tu.B.2302, Tu.B.2303,Tu.B.2304,Tu.B.2305,Tu.B.3 I 1, Tu.B.4 I 0,Tu.B.4 I 4,Tu.B.4 I 5,Tu.C.2656, We.B.300, We.B.3 I157, We.B.3246, We.B.33 I15, We.B.33 I19, We.B.3320, We.B.3343, We.B.552, We.C.342 I, We.C.3458 pneumonia N o.8. 121 6, MNo.8. 1222, MNo.8B.1225, No.8. 1230, No.8.1285, No.8. 1379, Th.B.4222,TuB. 1I I Tu.B. I I6,Tu.B.2 146, Tu. B.2 15 6, Tu. B.2 I161,Tu. 8.2 176, Tu. B.2 I177, Tu. B.2 I18 I, Tu. B.2290, Tu.B.2293,Tu.B.2298,Tu.B.2300, We.B.3222, We.B.33 I15, We.B.33 18, We.B.33 I19, We.C.3433 pneumonitis N o.B.1 225, Th.A.4059, Tu. B. I16, Tu.B.2296, We.B. 110 pneumochorax No.8.1 225, We.B.300 pol gene Tu.A.2086 politics Pub.D. I1405, Th.C.4760,Th.C.4789, Th.C.4848,Th.D.235,Th.D.4936, Th.D.4939,Th.D.4976,Th.D.4989, Th. D.4994, Th. D.5002, Tu. D.484, We.B.3 I142, We.D.230, We.D.360, We.D.3644, We.D.38 I18, We.D.494, We.D.59lI polyclonal activation We.A.3003 polymerase chain reaction (PCR) No.A. 1092, No.A. I1lO5, No.A. 160, No.A. I161, No.A.395, No.8. 1219, No.8.1224, NoB. 1248, No.8.1355, No.8. 180, No.8.3 10, No.8.3 I I, No.C. 1424, No.C. 1532, No.C. 1536, NoC. I1668, Pob.A. 1004, PubA. 1020, Pub.C. I 11I2, Th.A. I143, Th.A.272, Th.A.394, Th.A.4030, Th.A.4035, Th.A.4037, Th.A.4069, Th.A.4076, Th.A.4078, Th. B. I18 I, Th.B. 182, Th. B.302, Th. B.41I67, Th. B.421I2, Th. B.422 I, Th.B.4223,Th.B.4263,Th.B.4327, Th. D.4973, Tu.A. I154, Tu.A.2018, Tu.A.2052, To.A.2066, Tu.A.2086, Tu.A.2092, Tu.A.209 3, Tu.A.2 109, Tu.A.373, Tu.A.5 I13, Tu. B. I185, Tu.B.2 I154, Tu.B.2 I 68,Tu.B.2 I 72,Tu.B.2 173, Tu.B.22 I I,To.B.22 I13,lTu.B.2266, Tu.B.3 IS, Tu.C.223, Tu.C.2577, Tu.C.2582, Tu.C.2604,TuC.43 I, We.A. 166, We.A. 167, We.A.3083, We.A.3083, We.A.520, We.A.52 I, We.A.522, We.B. I1I4, We.B.32 I13, We.B.32 14, We.B.3234, We.B.3287, We.B.3298, We.8.3299, We.B.3328, We.B.3356, We.B.530, We.C.33 I, We.C.333, We.C.340, We.C.3426, We.C.3472 Th. D.25 3, Th. D.49 I12, Th. D.4979, Th.D.5058,Th.D.506 I,Th.D.5066, Th.D.5072,Th.D.5073,Th.D.5074, Tu.D.2735, Tu.D.2945, We.B.1I73, We.D.3677, We.D.368 I, We.D.374 1, We.D.3783, We.D.3903, We.D.492 PPD skin test No.8. I1365, No.8. I1368, No.8.1I370, No.C. I642, MoC. I649, Pub. B.1I089, Pub.B. I 095, We.B. I175, We.C.3406 preclinical testing MNo.A. I05 6, MNo.A. I08 6, MNo.A. I087, Th.D.50 I 2,Tu.B.2283 predictive value No.8.1I226, MoC. I573, Mo.D. I724, Pub.B. I1084, Pub.B. I 094,Th.A.392, ThB. I 73,Th.B.4 I 97,Th.B.4330, Th. C.4809, Tu.A.2007, Tu. A. 384, Tu.B.2 I 78,Tu.B.2343, We.B.4 I10, We.C.3446, We.C.3466, We.C.3534 pregnancy No.B. I1I30, No.B. I1325, No.8.54 I, No.8.542, No.8.S43, Ma.C. I1446, Ma.C. I48S, Ma.C. I488, Ma.C.1I492, Ma.C. I1562, Ma.C. I1620, No.C.2 I I, No.C.33 I, No.D. I707, No.D. I1723, Pub.B. I065, Pub.C. I1I80, Pub.C. I1261I, Pub.C. I1286, Pub.D. I 31I5,Th.B.4327, Th.C.344, Th.C.4 I12, Th.C.4 I15, Th.C.4592, Th.C.4593,Th.C.46 I 2,Th.C.4620, Th.C.4705,Th.C.4727,Th.C.483 I, Th.D.4932,Th.D.4960,Tu.B.2253, Tu.B.2325,Tu.B.4 I 3,Tu.C.2 I 3,Tu.C.2456, Tu.C.2457,Tu.C.2463,Tu.C.2464, Tu.C.2482,Tu.C.2569,Tu.C.257 I, Tu.C.2572,Tu.C.2578,Tu.C.2580, Tu.C.2586, Tu.C.2595, Tu.C.2600, Tu.C.260 I,Tu.C.2603,Tu.C.2606, Tu.C.2607, Tu.C.26 I19, Tu.C.345, Tu.C.443, Tu.C.445,Tu.C.562, We.B. I193, We.B.1I95, We.B. I196, We.B.3 I163, We.B.3228, We.B.3335, We.C.330, We.C.33 I, We.C.3398, We.C.3399, We.C.340 I, We.C.3584, We.C.3585, We.C.3587, We.C.3590 prejudice No.D. I1839, No.D.1I924, Pub.D. I1372, Pub.D. I1374, Pub.D. I141I2, Pub.D. I1482, Th.C.4522,Th.C.4730,Th.D.245, Th.D.4952,Tu.D.23 I,Tu.D.272 I, Tu.D.2954, We.D.3609, We.D.3628, We.D.3750 premature membrane rupture, SEE also vertical transmission Tu.C.44 I pretest HIV counselling, SEE testing, counselling Mo.D.1I707, No.D. I743, Pub.C. I1I127, Pub.D. I 420,Th.C.4725,Th.C.483 I, Th.D.4954,Th.D.5036,Tu.C.2464, Tu.C.2566,Tu.D.2908,Tu.D.2937, We.C.3587 prevalence No.8. I1361I, No.8.424, Ma.C. I1403, Ma.C. I41I2, Ma.C. I141I4, Ma.C. I1422, Ma.C. I437, Ma.C. I1454, Ma.C. I1462, Ma.C. I468, Ma.C. I1469, Ma.C. I1484, Ma.C. I485, Ma.C.1I492, Ma.C.1I496, Mo.C.I1503, NoCI 151, Ma.CIS14, Ma.C. I552, Ma.C. I559, Ma.C. I61I4, No.C.454,Th.C.34 I,Tu.B.2 I 37,Tu.C.57 I, We.B.3246, We.D.233, We.D.3662 prevalence, heterosexuals, SEE heterosexuals, prevalence Ma.C. I 427, Th.B.4 I140, Th.D.5 I133 prevalence, methodology Ma.C.1I4 I6, Ma.C. I1520, Ma.C. I1550, Na.C.200, Pub.B. I1070, Th.C. I123, Th.C.34 I,Th.C.4366,Tu.C.224, We.C.224, We.C.344, We.D.3685 prevalence, other Ma.C.1I42S, Ma.C. I1443, Ma.C.1I 09, No.C.224, Pub.B. I1069. Pub.D. I1488, Th. D.4878, Th. D.5 I120, fu.B.2240 prevalence, SEE also geographical regions M o.A.5 I0, MNo.8B. I1I49, MNo.8B.1I208, Ma.C. I 04, Ma.C. I1505, Ma.C. I1578, Ma.C. I1580, Ma.C. I1627, Ma.C. I1628, Ma.C. I1633, Ma.C. I 664,Th.D.235, Tu.C.224,Tu.D.2906, We.D.3630 prevalence, SEE children Ma.C. I1564, No.D, I779, Th.B.4276, We.C.3447 prevalence, SEE gay men Pub.C. I I22,Tu.C.241I0, We.C.562, We.C.563 prevalence, SEE IDUs No.8. I1I82, Ma.C. I1504, Pub.C. I1I132, We.B.3246, We.C.3556, We.C.46 I prevalence, SEE sex workers Ma.C. I1432, No.D. I1687, Pub.B. I1042, Pub.B. I 048,Th.C.4684,Tu.C.2624, Tu.C.2637,Tu.C.2673 prevalence, SEE women Ma.C.14S8, Ma.C.1I 5I9. No.C.33 I, Tu.C.2458, Tu.C.2463, Tu.C.2473, Tu.C.2623 preventative vaccine No.A.406, No.A.520, Ma.C. I1S9 I. Ma.C. I1592, Pub.C. I I85,Th.C. I123, Tu.A.2 101, Tu.A.284, We.B.3373, We.C.21I3 prevention No.8. I1209, Ma.C. I1406, Ma.C. I1S5I5, Ma.C.1I579, Ma.C. I1584, Ma.C. I1607, Ma.C. 1619, No.D.I3 I, No.D.172 I, No.D.1I727, No.D.1I74I, No.D, I779, No.D. I1800, No.D.1816. No.D.1I823, No.D.1I824, No.D.1I836, No.D.1I856, No.D.1I859, No.D.1I899, No.D.1I900, No.D.1I90I, No.D. I909, No.D.1I927, No.D.1I936, No.D.25 I, No.D.353, No.D.484, NoD.60 I, Pub.A. I1030, Pub.C.I I117, Pub.C.l1127, Pub.C.l1131, Pub.C.1I I36. Pub.C. I1I147, Pub.C. I1I74, Pub.C. I1I89, Pub.C. I1I94, Pub.C. I1I97, Pub.C. I1200, Pub.C. I1201I, Pub.C. I1202, Pub.C.I209, Pub.C.I121 I, Pub.C.l22l, Pub.C. I1225, Pub.C. I1228, Pub.C. I1230, Pub.C. I1233, Pub.C. I1239, Pub.C. I1250, Pub.C. 1256, Pub.C. I1259, Pub.C. I1264, Pub.C. I1268, Pub.C. I1276, Pub.C. I1282, Pub.D. 1302, Pub.D. 1303, Pub.D. I131I2, Pub.D. 131 3, Pub.D. 1335, Pub.D. I1361, Pub.D. 365, Pub.D. 1378, Pub.D. I1386. Pub.D. 1388, Pub.D. 1394, Pub.D. 141 3, Pub.D.I4l8, Pub.D.I1431, Pub.D.l433, Pub.D. 1435, Pub.D. 1436, Pub.D. 144 1, Th.C.4724, Th.C.4739, Th.C.4767, Th.C.4770,Th.C.4773, Th.C.4775,

/ 516
Pages

Actions

file_download Download Options Download this page PDF - Pages 491- Image - Page 494 Plain Text - Page 494

About this Item

Title
Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]
Author
International AIDS Society
Canvas
Page 494 - Comprehensive Index
Publication
1996
Subject terms
abstracts (summaries)
Item type:
abstracts (summaries)

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0110.046
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0110.046/504

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0110.046

Cite this Item

Full citation
"Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0110.046. University of Michigan Library Digital Collections. Accessed May 11, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.

Downloading...

Download PDF Cancel